HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 - - 48-week trial will enroll approximately 150 individuals, and first sites are now open for ...

RAP-219’s lead program demonstrated robust and consistent activity in patients with focal onset seizures (FOS) in Phase 2a trial; initiation of Phase 3 program expected in the second quarter of 2026 ...

This marks U.S. News & World Report's first-ever evaluation of home health providers nationwide, identifying top-performing ...

The University of Chicago Medicine launched a new mobile dental clinic that brings no-cost oral healthcare directly to community members.

By sticking to daylight savings time, British Columbians will strike a blow for common sense and possibly save some lives ...